Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $.001 per share
Symbol
MBRX on Nasdaq
Shares outstanding
31,794,008
Price per share
$0.28
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
778,273
Total reported value
$412,657
% of total 13F portfolios
0%
Share change
+345,621
Value change
+$243,574
Number of holders
24
Price from insider filings
$0.28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 5% -44% $872,587 +$185,087 1,586,521 +27% Armistice Capital, LLC 30 Jun 2025

As of 30 Sep 2025, 24 institutional investors reported holding 778,273 shares of Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX). This represents 2.4% of the company’s total 31,794,008 outstanding shares.

Institutional Holders of Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$149,249 $0.28 0
2025 Q3 778,273 $412,657 +$243,574 $0.53 24
2025 Q2 432,652 $130,873 -$1,202,132 $0.30 22
2025 Q1 1,478,032 $1,438,584 +$969,253 $0.97 21
2024 Q4 464,699 $790,000 +$6,340 $1.70 20
2024 Q3 460,563 $1,308,014 +$417,028 $2.84 17
2024 Q2 313,722 $1,103,728 +$192,754 $3.52 15
2024 Q1 258,464 $1,528,467 +$1,528,467 $5.91 18